As of November 10, 2026, 7 holders' latest Schedule 13D or 13G filings report owning 5% or more of Dolby Laboratories, Inc. The largest reported stake is Dagmar Dolby's, at 36%. 10 filings are on record since February 11, 2026 (Schedule 13D/A, February 13, 2026).
Sell to companies like Dolby Laboratories, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: First Trust Portfolios L.P. · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 17,727 · SCHEDULE 13G, 2026-10-27
- · Reporting person: Bank of New York Mellon Corp · Sole voting: 5,077,390 · Shared voting: 4,942 · Sole dispositive: 3,184,800 · Shared dispositive: 1,933,775 · SCHEDULE 13G/A, 2026-10-22
- · Reporting person: BlackRock, Inc. · Sole voting: 5,849,800 · Shared voting: 0 · Sole dispositive: 6,041,219 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-06-04
- · Holder: Morgan Stanley · Percent: 8.2% · SCHEDULE 13G/A
- · Holder: Vanguard Capital Management · Percent: 5.24% · SCHEDULE 13G
Dolby Laboratories, Inc. has 10 Schedule 13D or 13G filings on record since 2026-02-11. 7 holders' latest filing reports 5% or more of common. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 36% | 34,368,358 | SCHEDULE 13D/A, 2026-02-13 | 2026-02-11 | |
| BlackRock, Inc. | 10% | 6,041,219 | SCHEDULE 13G/A, 2026-06-04 | 2026-05-31 |
| Bank of New York Mellon Corp | 8.6% | 5,118,575 | SCHEDULE 13G/A, 2026-10-22 | 2026-09-30 |
| Vanguard Portfolio Management | 8.24% | 5,019,900 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| 8.2% | 5,020,777 | SCHEDULE 13G/A, 2026-05-11 | 2026-03-31 | |
| Vanguard Capital Management | 5.24% | 3,193,409 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| First Trust Portfolios L.P. | 5.09% | 3,023,033 | SCHEDULE 13G, 2026-10-27 | 2026-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
Holding shares or following this stake? See who's behind Dolby Laboratories, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Dolby Laboratories, Inc. and the records around it.
Dolby Laboratories, Inc. elsewhere on the record
- Leadership changes Aug 2026
- Who owns it
Companies that share a holder
- Bank of New York Mellon Corp also filed stake reports on 26 other companies: FIRST HORIZON CORP (Oct 2026), First Watch Restaurant Group, Inc. (Oct 2026), Hess Midstream LP (Oct 2026)
- First Trust Portfolios L.P. also filed stake reports on 105 other companies: First Trust Exchange-Traded Fund (Nov 2026), First Trust Exchange-Traded Fund IV (Nov 2026), First Trust Exchange-Traded Fund VIII (Nov 2026)
- Morgan Stanley also filed stake reports on 182 other companies: MDA Space Ltd. (Nov 2026), RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (Oct 2026), Arbutus Biopharma Corp (Oct 2026)
Watch Dolby Laboratories, Inc.
Get an email when Dolby Laboratories, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Dolby Laboratories, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Dolby Laboratories, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dolby Laboratories, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,849,800 | 0 | 6,041,219 | 0 | SCHEDULE 13G/A, 2026-06-04 |
| Bank of New York Mellon Corp | 5,077,390 | 4,942 | 3,184,800 | 1,933,775 | SCHEDULE 13G/A, 2026-10-22 |
| BNY Mellon IHC, LLC | 4,395,142 | 0 | 2,515,675 | 1,917,765 | SCHEDULE 13G/A, 2026-10-22 |
| MBC Investments Corp | 4,395,142 | 0 | 2,515,675 | 1,917,765 | SCHEDULE 13G/A, 2026-10-22 |
| Newton Investment Management North America, LLC | 3,923,543 | 0 | 2,028,166 | 1,898,444 | SCHEDULE 13G/A, 2026-10-22 |
| First Trust Portfolios L.P. | 0 | 0 | 0 | 17,727 | SCHEDULE 13G, 2026-10-27 |
| First Trust Advisors L.P. | 0 | 3,005,306 | 0 | 3,023,033 | SCHEDULE 13G, 2026-10-27 |
| The Charger Corporation | 0 | 3,005,306 | 0 | 3,023,033 | SCHEDULE 13G, 2026-10-27 |
The latest filing identifies Dolby Laboratories, Inc. by CUSIP 25659T107 and gives its principal executive office as 1275 Market Street, San Francisco, CA 94103 (SCHEDULE 13G, 2026-10-27).
Purpose of Transaction (Item 4)
Dagmar Dolby
Item 4 of the Statement is amended by adding the following at the end thereof: There was a decrease in the Reporting Persons' beneficial holdings of more than one percent of the outstanding shares of Class A Common Stock resulting from the gifting of (i) 43,500 shares of Class A Common Stock beneficially owned by the Dagmar Dolby Fund and (ii) 890,000 shares of Class A Common Stock beneficially owned by the Dagmar Dolby Trust (collectively, the "Transfers"), partially offset by 3,140 shares of Class A Common Stock issued to David E. Dolby upon the vesting of restricted stock units. The Transfers were effected solely for charitable gifting purposes, and were transfers for no value without the payment or receipt of any funds or other consideration by the Reporting Persons in exchange therefor.Item 4 of the SCHEDULE 13D/A filed 2026-02-13
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-02-11 | Morgan Stanley | 10.2% | SCHEDULE 13G/A |
| 2026-02-13 | Dagmar Dolby | 36% | SCHEDULE 13D/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-28 | Bank of New York Mellon Corp | 7.4% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Capital Management | 5.24% | SCHEDULE 13G |
| 2026-04-29 | Vanguard Portfolio Management | 8.24% | SCHEDULE 13G |
| 2026-05-11 | Morgan Stanley | 8.2% | SCHEDULE 13G/A |
| 2026-06-04 | BlackRock, Inc. | 10% | SCHEDULE 13G/A |
| 2026-10-22 | Bank of New York Mellon Corp | 8.6% | SCHEDULE 13G/A |
| 2026-10-27 | First Trust Portfolios L.P. | 5.09% | SCHEDULE 13G |
Questions about who owns Dolby Laboratories, Inc.
Who owns Dolby Laboratories, Inc.?
On this page, 7 holders' latest ownership filings report 5% or more of Dolby Laboratories, Inc.: Dagmar Dolby (36%, Schedule 13D/A, filed 2026-02-13), BlackRock, Inc. (10%, Schedule 13G/A, filed 2026-06-04), Bank of New York Mellon Corp (8.6%, Schedule 13G/A, filed 2026-10-22), Vanguard Portfolio Management (8.24%, Schedule 13G, filed 2026-04-29) and Morgan Stanley (8.2%, Schedule 13G/A, filed 2026-05-11); 2 more are listed above.
Who are the largest shareholders of Dolby Laboratories, Inc.?
By the share each holder's latest filing reports, the largest holders of Dolby Laboratories, Inc. on this page are Dagmar Dolby (36%), BlackRock, Inc. (10%) and Bank of New York Mellon Corp (8.6%).
When did Dagmar Dolby buy into Dolby Laboratories, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Dagmar Dolby on this page is the Schedule 13D/A, filed 2026-02-13, reporting 36%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Dolby Laboratories, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 27, 2026 | Leadership change: Marc Whitten appointed, President and Chief Executive Officer | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Dolby Laboratories, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.